AA,Alcoa swings to 1st-quarter profit as revenue risesUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 2-Alcoa posts profit after year-earlier loss, confirms '15 outlookAlcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday. CHICAGO, April 8 Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.   UPDATE 2-Alcoa posts profit after year-earlier loss, confirms '15 outlookAlcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday. CHICAGO, April 8 Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 2-Alcoa posts profit after year-earlier loss, confirms '15 outlookAlcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday. CHICAGO, April 8 Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.    US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 2-Alcoa posts profit after year-earlier loss, confirms '15 outlookAlcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday. CHICAGO, April 8 Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.   UPDATE 2-Alcoa posts profit after year-earlier loss, confirms '15 outlookAlcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday. CHICAGO, April 8 Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 2-Alcoa posts profit after year-earlier loss, confirms '15 outlookAlcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday. CHICAGO, April 8 Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.   CHICAGO, April 8 Metals company Alcoa Inc  kicked off the first-quarter earnings season on Wednesday, reporting that it swung to a quarterly profit on a jump in revenue, primarily in its value-added automotive and aerospace businesses.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 2-Alcoa posts profit after year-earlier loss, confirms '15 outlookAlcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday. CHICAGO, April 8 Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.   UPDATE 2-Alcoa posts profit after year-earlier loss, confirms '15 outlookAlcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday. CHICAGO, April 8 Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 2-Alcoa posts profit after year-earlier loss, confirms '15 outlookAlcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.  Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday. CHICAGO, April 8 Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.Alcoa posts profit after year-earlier loss, confirms '15 outlook CHICAGO Alcoa Inc earned a profit in the first quarter after a year-earlier loss, reflecting its ongoing shift from traditional  smelting and refining to value-added businesses such as automotive and aerospace, the aluminum producer said on Wednesday.    
GOOGL,Court questions Google on patent values in Microsoft caseCourt questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.  Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents. SAN FRANCISCO, April 8 A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's  bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.  
GOOG,Court questions Google on patent values in Microsoft caseCourt questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.  Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents. SAN FRANCISCO, April 8 A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's  bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.  
AMZN,Global Fashion Group hires ex-Amazon.com exec as CEO FRANKFURT, April 8 Global Fashion Group (GFG), formed out of five Kinnevik- and Rocket Internet-  backed online fashion start-ups active across dozens of emerging markets, has hired the former head of Amazon  France as its new chief executive. 
AAL,U.S. regulator grants American Airlines, US Airways single certificate April 8 American Airlines and US Airways were given a single operating certificate from U.S. regulators, marking a milestone in their integration since the carriers merged in December 2013, parent American Airlines Group Inc  said. 
AXP,Alibaba to help Bigcommerce clients tap China supplier network SAN FRANCISCO Alibaba Group Holding Ltd has forged a deal to allow online shopping startup Bigcommerce's 70,000-plus clients to more easily buy from top-ranked Chinese suppliers and manufacturers on Alibaba.com. 
APA,Apache exits Australia E&P; business with $2.1 bln sale April 8 U.S. oil and gas company Apache Corp  said it would exit its exploration and production business in Australia by selling its unit there to a consortium of private equity funds for $2.1 billion in cash. 
AAPL,Global tech giants say 'under review' by Australia tax officeSlow apps, low battery life limit appeal of Apple Watch: reviewersREFILE-Apple faces local battles as it prepares global payments push * Apple Pay global expansion slowed by local payment differences  REFILE-Apple faces local battles as it prepares global payments push * Apple Pay global expansion slowed by local payment differences Apple Inc's  "beautiful" and "stylish" smartwatch could make life easier for people on the move, reviewers say, but the gadget gets poor marks for battery life and slow-loading apps.REFILE-Apple faces local battles as it prepares global payments push * Apple Pay global expansion slowed by local payment differences   Slow apps, low battery life limit appeal of Apple Watch: reviewersREFILE-Apple faces local battles as it prepares global payments push * Apple Pay global expansion slowed by local payment differences  REFILE-Apple faces local battles as it prepares global payments push * Apple Pay global expansion slowed by local payment differences Apple Inc's  "beautiful" and "stylish" smartwatch could make life easier for people on the move, reviewers say, but the gadget gets poor marks for battery life and slow-loading apps.REFILE-Apple faces local battles as it prepares global payments push * Apple Pay global expansion slowed by local payment differences  SYDNEY, April 8 Global tech giants Google , Apple and Microsoft are "under review" by the Australian Tax Office (ATO), senior executives said on Wednesday, as politicians grilled them about corporate tax avoidance.Slow apps, low battery life limit appeal of Apple Watch: reviewersREFILE-Apple faces local battles as it prepares global payments push * Apple Pay global expansion slowed by local payment differences  REFILE-Apple faces local battles as it prepares global payments push * Apple Pay global expansion slowed by local payment differences Apple Inc's  "beautiful" and "stylish" smartwatch could make life easier for people on the move, reviewers say, but the gadget gets poor marks for battery life and slow-loading apps.REFILE-Apple faces local battles as it prepares global payments push * Apple Pay global expansion slowed by local payment differences   
T,UPDATE 1-U.S. FCC imposes $25 mln fine on AT&T; over customer data breachU.S. FCC imposes $25 million fine on AT&T; over customer data breach NEW YORK The Federal Communications Commission reached a $25 million settlement with AT&T; Inc over a consumer data breach at call centers in Mexico, Colombia and the Philippines, the U.S. communications regulator said on Wednesday.  U.S. FCC imposes $25 million fine on AT&T; over customer data breach NEW YORK The Federal Communications Commission reached a $25 million settlement with AT&T; Inc over a consumer data breach at call centers in Mexico, Colombia and the Philippines, the U.S. communications regulator said on Wednesday. NEW YORK, April 8 The Federal Communications Commission reached a $25 million settlement with AT&T; Inc  over a consumer data breach at call centers in Mexico, Colombia and the Philippines, the U.S. communications regulator said on Wednesday.U.S. FCC imposes $25 million fine on AT&T; over customer data breach NEW YORK The Federal Communications Commission reached a $25 million settlement with AT&T; Inc over a consumer data breach at call centers in Mexico, Colombia and the Philippines, the U.S. communications regulator said on Wednesday.  
BAC,Bank of America appoints co-heads of global investment bankingBank of America appoints co-heads of global investment bankingMOVES-Assef, De Giorgi to head global investment banking at BofA LONDON, April 8 (IFR) - Bank of America Merrill Lynch has promoted two of its most senior investment bankers to co-head the new position of global investment banking as part of plans to enhance its coverage efforts, according to an internal memo seen by IFR.  MOVES-Assef, De Giorgi to head global investment banking at BofA LONDON, April 8 (IFR) - Bank of America Merrill Lynch has promoted two of its most senior investment bankers to co-head the new position of global investment banking as part of plans to enhance its coverage efforts, according to an internal memo seen by IFR. Bank of America Corp appointed Karim Assef and Diego De Giorgi co-heads of global investment banking, according to an internal memo seen by Reuters.MOVES-Assef, De Giorgi to head global investment banking at BofA LONDON, April 8 (IFR) - Bank of America Merrill Lynch has promoted two of its most senior investment bankers to co-head the new position of global investment banking as part of plans to enhance its coverage efforts, according to an internal memo seen by IFR.   Bank of America appoints co-heads of global investment bankingMOVES-Assef, De Giorgi to head global investment banking at BofA LONDON, April 8 (IFR) - Bank of America Merrill Lynch has promoted two of its most senior investment bankers to co-head the new position of global investment banking as part of plans to enhance its coverage efforts, according to an internal memo seen by IFR.  MOVES-Assef, De Giorgi to head global investment banking at BofA LONDON, April 8 (IFR) - Bank of America Merrill Lynch has promoted two of its most senior investment bankers to co-head the new position of global investment banking as part of plans to enhance its coverage efforts, according to an internal memo seen by IFR. Bank of America Corp appointed Karim Assef and Diego De Giorgi co-heads of global investment banking, according to an internal memo seen by Reuters.MOVES-Assef, De Giorgi to head global investment banking at BofA LONDON, April 8 (IFR) - Bank of America Merrill Lynch has promoted two of its most senior investment bankers to co-head the new position of global investment banking as part of plans to enhance its coverage efforts, according to an internal memo seen by IFR.  April 8 Bank of America Corp appointed Karim Assef and Diego De Giorgi co-heads of global investment banking, according to an internal memo seen by Reuters.Bank of America appoints co-heads of global investment bankingMOVES-Assef, De Giorgi to head global investment banking at BofA LONDON, April 8 (IFR) - Bank of America Merrill Lynch has promoted two of its most senior investment bankers to co-head the new position of global investment banking as part of plans to enhance its coverage efforts, according to an internal memo seen by IFR.  MOVES-Assef, De Giorgi to head global investment banking at BofA LONDON, April 8 (IFR) - Bank of America Merrill Lynch has promoted two of its most senior investment bankers to co-head the new position of global investment banking as part of plans to enhance its coverage efforts, according to an internal memo seen by IFR. Bank of America Corp appointed Karim Assef and Diego De Giorgi co-heads of global investment banking, according to an internal memo seen by Reuters.MOVES-Assef, De Giorgi to head global investment banking at BofA LONDON, April 8 (IFR) - Bank of America Merrill Lynch has promoted two of its most senior investment bankers to co-head the new position of global investment banking as part of plans to enhance its coverage efforts, according to an internal memo seen by IFR.   
COP,BRIEF-Conocophillips CEO says no plans to sell the companyConoco CEO sees ramping up shale rigs when oil price recovers HOUSTON, April 8 ConocoPhillips, the largest independent producer of oil and natural gas, plans to add drilling rigs in 2017 in key U.S. shale acreage based on its expectations for a crude price recovery, the company's chief executive said on Wednesday.  Conoco CEO sees ramping up shale rigs when oil price recovers HOUSTON, April 8 ConocoPhillips, the largest independent producer of oil and natural gas, plans to add drilling rigs in 2017 in key U.S. shale acreage based on its expectations for a crude price recovery, the company's chief executive said on Wednesday. * CEO says "no" when asked by an analyst if he has made any plans to sell the company  Further company coverage:    (Reporting By Anna Driver)Conoco CEO sees ramping up shale rigs when oil price recovers HOUSTON, April 8 ConocoPhillips, the largest independent producer of oil and natural gas, plans to add drilling rigs in 2017 in key U.S. shale acreage based on its expectations for a crude price recovery, the company's chief executive said on Wednesday.  
XOM,INDONESIA PRESS-Exxon, Niko hand back oil and gas blocks - KontanShell seeking to buy BG in first oil super-merger in over a decadeUPDATE 1-Shell agrees $70 billion deal to buy BGFactbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   LONDON, April 8 Royal Dutch Shell said on Wednesday it had agreed to buy BG Group for 47 billion pounds ($70 billion) in a bid to close the gap on the world's biggest oil major, U.S. ExxonMobil.Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:     UPDATE 1-Shell agrees $70 billion deal to buy BGFactbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   LONDON, April 8 Royal Dutch Shell said on Wednesday it had agreed to buy BG Group for 47 billion pounds ($70 billion) in a bid to close the gap on the world's biggest oil major, U.S. ExxonMobil.Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Royal Dutch Shell  is in advanced talks to buy BG Group  in the first oil super-merger in more than a decade, seeking to extend its lead in gas production and close the gap with the world's biggest oil major, U.S. ExxonMobil .UPDATE 1-Shell agrees $70 billion deal to buy BGFactbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   LONDON, April 8 Royal Dutch Shell said on Wednesday it had agreed to buy BG Group for 47 billion pounds ($70 billion) in a bid to close the gap on the world's biggest oil major, U.S. ExxonMobil.Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:      Shell seeking to buy BG in first oil super-merger in over a decadeUPDATE 1-Shell agrees $70 billion deal to buy BGFactbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   LONDON, April 8 Royal Dutch Shell said on Wednesday it had agreed to buy BG Group for 47 billion pounds ($70 billion) in a bid to close the gap on the world's biggest oil major, U.S. ExxonMobil.Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:     UPDATE 1-Shell agrees $70 billion deal to buy BGFactbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   LONDON, April 8 Royal Dutch Shell said on Wednesday it had agreed to buy BG Group for 47 billion pounds ($70 billion) in a bid to close the gap on the world's biggest oil major, U.S. ExxonMobil.Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Royal Dutch Shell  is in advanced talks to buy BG Group  in the first oil super-merger in more than a decade, seeking to extend its lead in gas production and close the gap with the world's biggest oil major, U.S. ExxonMobil .UPDATE 1-Shell agrees $70 billion deal to buy BGFactbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   LONDON, April 8 Royal Dutch Shell said on Wednesday it had agreed to buy BG Group for 47 billion pounds ($70 billion) in a bid to close the gap on the world's biggest oil major, U.S. ExxonMobil.Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:     Exxon Mobil Corp has returned four oil and gas blocks to the Indonesian government after exploration studies found reserves were not economical for the firm to extract, the Kontan newspaper reported, quoting ExxonMobil Indonesia vice-president for government affairs Erwin Maryoto.Shell seeking to buy BG in first oil super-merger in over a decadeUPDATE 1-Shell agrees $70 billion deal to buy BGFactbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   LONDON, April 8 Royal Dutch Shell said on Wednesday it had agreed to buy BG Group for 47 billion pounds ($70 billion) in a bid to close the gap on the world's biggest oil major, U.S. ExxonMobil.Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:     UPDATE 1-Shell agrees $70 billion deal to buy BGFactbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   LONDON, April 8 Royal Dutch Shell said on Wednesday it had agreed to buy BG Group for 47 billion pounds ($70 billion) in a bid to close the gap on the world's biggest oil major, U.S. ExxonMobil.Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Royal Dutch Shell  is in advanced talks to buy BG Group  in the first oil super-merger in more than a decade, seeking to extend its lead in gas production and close the gap with the world's biggest oil major, U.S. ExxonMobil .UPDATE 1-Shell agrees $70 billion deal to buy BGFactbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:    Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   LONDON, April 8 Royal Dutch Shell said on Wednesday it had agreed to buy BG Group for 47 billion pounds ($70 billion) in a bid to close the gap on the world's biggest oil major, U.S. ExxonMobil.Factbox: What the Shell-BG deal says about oil prices and deal makingREFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:   REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  LONDON Royal Dutch Shell  agreed to buy smaller rival BG Group  for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil  after a plunge in oil prices.REFILE-UPDATE 8-Shell challenges Exxon dominance with $70 bln bid for BGDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:  Deals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday: * BG developing ambitious projects in Brazil, Australia and EgyptDeals of the day- Mergers and acquisitions April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:      
FDX,GLOBAL MARKETS-Oil & gas mega-merger keeps stocks fizzing LONDON, April 8 Global stocks remained upbeat on Wednesday as a $70 billion mega-deal in the European oil and gas sector stoked the merger and acquisition fever that has gripped investors this week. 
FLIR,FLIR Systems to settle U.S. SEC bribery charges WASHINGTON, April 8 Defense contractor FLIR Systems Inc will pay $9.5 million to settle civil charges that it violated federal bribery laws by financing a "world tour" of personal travel for government officials in the Middle East, U.S. regulators said Wednesday. 
HRL,U.S. bird flu outbreak accelerates as wild ducks migrate north CHICAGO, April 8 A U.S. outbreak of a deadly strain of bird flu accelerated on Wednesday with the infection of a sixth turkey flock in Minnesota, the nation's top turkey-producing state, in less than a week. 
JPM,JPMorgan CEO defends bank size and breadth of product offerings NEW YORK, April 8 Jamie Dimon, chief executive officer of JPMorgan Chase & Co, the biggest U.S.-based bank, defended the size and business model of his company, which has been criticized as being too big and complicated. 
MAT,INSIGHT-Toy business attracts private equity as kids go green and retro NEW YORK, April 8 Striding confidently through Matty's Toy Stop in Manhasset, New York, Catie Tepedino, 7, is the sort of consumer who may hold the fate of the U.S. toy business in her own little fists. 
MSFT,Global tech giants say 'under review' by Australia tax officeCourt questions Google on patent values in Microsoft caseCourt questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.  Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents. SAN FRANCISCO, April 8 A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's  bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.   Court questions Google on patent values in Microsoft caseCourt questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.  Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents. SAN FRANCISCO, April 8 A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's  bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.  SYDNEY, April 8 Global tech giants Google , Apple and Microsoft are "under review" by the Australian Tax Office (ATO), senior executives said on Wednesday, as politicians grilled them about corporate tax avoidance.Court questions Google on patent values in Microsoft caseCourt questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.  Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents. SAN FRANCISCO, April 8 A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's  bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.Court questions Google on patent values in Microsoft case SAN FRANCISCO A U.S. appeals court appeared skeptical on Wednesday toward Google Inc's bid to charge Microsoft Corp a high royalty rate to use some of the Internet search provider's Motorola Mobility patents.   
MON,Chinese citizens sue government over transparency on Monsanto herbicide BEIJING, April 8 Three Chinese citizens are taking China's Ministry of Agriculture to court in a bid to make public a toxicology report supporting the approval of Monsanto's popular weedkiller, Roundup, 27 years ago. 
MYL,US STOCKS-Wall St ticks up but energy weighs after crude dropUS STOCKS-Wall St ticks up on M&A; but energy weighs as crude dropsUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.      US STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     * Fed's Dudley keeps June rate hike on the table depending on dataUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.       US STOCKS-Wall St ticks up on M&A; but energy weighs as crude dropsUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.      US STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     * Fed's Dudley keeps June rate hike on the table depending on dataUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.      * Fed's Dudley keeps June rate hike on the table depending on dataUS STOCKS-Wall St ticks up on M&A; but energy weighs as crude dropsUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.      US STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     * Fed's Dudley keeps June rate hike on the table depending on dataUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerDeals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.Deals of the day- Mergers and acquisitionsUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  April 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.       
NFLX,Insight: Does a happy employee make for a healthy stock price?REFILE-RPT-INSIGHT -Does a happy employee make for a healthy stock price? NEW YORK, April 7 When BlackRock, the world's largest asset manager,  evaluates potential stock purchases, its managers look at all the usual financial metrics.  REFILE-RPT-INSIGHT -Does a happy employee make for a healthy stock price? NEW YORK, April 7 When BlackRock, the world's largest asset manager,  evaluates potential stock purchases, its managers look at all the usual financial metrics. NEW YORK When BlackRock, the worlds largest asset manager, evaluates potential stock purchases, its managers look at all the usual financial metrics.REFILE-RPT-INSIGHT -Does a happy employee make for a healthy stock price? NEW YORK, April 7 When BlackRock, the world's largest asset manager,  evaluates potential stock purchases, its managers look at all the usual financial metrics.  
NEM,Newmont Mining says will build new Nevada gold mineUPDATE 1-Newmont Mining says will build new Nevada gold mine April 8 Newmont Mining Corp will go ahead with building the first phase of its Long Canyon gold mine in Nevada, the company, the biggest U.S.-based gold miner said on Wednesday.  UPDATE 1-Newmont Mining says will build new Nevada gold mine April 8 Newmont Mining Corp will go ahead with building the first phase of its Long Canyon gold mine in Nevada, the company, the biggest U.S.-based gold miner said on Wednesday. April 8 Newmont Mining Corp said on Wednesday it will go ahead with building the first phase of its Long Canyon gold mine in Nevada.UPDATE 1-Newmont Mining says will build new Nevada gold mine April 8 Newmont Mining Corp will go ahead with building the first phase of its Long Canyon gold mine in Nevada, the company, the biggest U.S.-based gold miner said on Wednesday.  
NOC,UPDATE 2-Ex-U.S Army colonel tied to Tilton equity firm reaches plea deal April 8 A retired U.S. Army colonel has agreed to plead guilty to negotiating a job with financier Lynn Tilton's private equity firm while also taking steps to ensure a helicopter company it controlled got paid faster by the Department of Defense. 
PRGO,Mylan proposes to buy Perrigo for about $29 blnUS STOCKS-Wall St ticks up on M&A; but energy weighs as crude dropsUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.      US STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     * Fed's Dudley keeps June rate hike on the table depending on dataUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.       US STOCKS-Wall St ticks up on M&A; but energy weighs as crude dropsUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.      US STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     * Fed's Dudley keeps June rate hike on the table depending on dataUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.      April 8 Generic drugmaker Mylan NV  proposed to buy Perrigo Co Plc for about $29 billion in cash and stock.US STOCKS-Wall St ticks up on M&A; but energy weighs as crude dropsUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.      US STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     * Fed's Dudley keeps June rate hike on the table depending on dataUS STOCKS-Wall St rises in volatile trading after Fed minutesPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.     Perrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    * Fed minutes indicate rate hike in 2015, but members differ on monthPerrigo options attracted large bullish bet ahead of Mylan offerPerrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.    Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   NEW YORK, April 8 Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV to buy the company, options data shows.Perrigo options attracted large bullish bet ahead of Mylan offerUS STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.   US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  NEW YORK Perrigo Co Plc's  options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV  to buy the company, options data shows.US STOCKS-Wall St ends with modest gains after Fed minutesUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.  UPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach. * Fed minutes indicate rate hike in 2015; members differ on monthUPDATE 3-Generic drugmaker Mylan offers $29 bln for Perrigo April 8 Generic drugmaker Mylan NV has offered to buy Perrigo Co Plc for about $29 billion in cash and stock, a deal that would make Mylan a major player in over-the-counter consumer products and extend its geographic reach.       
